Con: Continuation of Aspirin/Clopidogrel for Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 4, 2007, Pages 606-609

  Spiess, Bruce D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

aspirin; bleeding; clopidogrel; coronary artery bypass graft surgery; outcomes; transfusion

Indexed keywords

EID: 34547224567     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2007.04.018     Document Type: Note

References (45)

1. Cicala C., and Cirino G. Linkage between inflammation and coagulation: An update on the molecular basis of crosstalk. Life Sci 62 (1998) 1817-1824
2. Rinder C. In: Spiess B.D., Spence R.K., Shander A., et al. (Eds). Platelet physiology: Cellular and protein interactions (2006), Lippincott, Williams and Wilkins, Baltimore, MD 93-102
3. Kulkarni S., Dopheide S.M., Yap S.L., et al. A revised model of platelet aggregation. J Clin Invest 105 (2000) 783-791
4. Body S.C., and Morse D.S. Coagulation, transfusion and cardiac surgery. In: Spiess B.D., Spence R.K., and Shander A. (Eds). Perioperative Transfusion Medicine (2006), Williams and Wilkins, Baltimore, MD, Lippincott 513-556
5. Kobzar G., Mardla V., Ratsep I., et al. Platelet activity before and after coronary artery bypass grafting. Platelets 17 (2006) 289-291
6. Levy J.H. The relationship between coagulation, inflammation and endothelium: Inflammation responds. In: Spiess B.D. (Ed). The Relationship Between Coagulation, Inflammation and Endothelium, SCA Monograph (2000), Lippincott, Williams and Wilkins, Baltimore, MD 91-104
7. Edmunds Jr. L.H., and Colman R.W. Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82 (2006) 2315-2322
8. van der Linden J., Lindvall G., and Sartipy U. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: A double-blind, placebo-controlled, randomized clinical trial. Circulation 112 (2005) I276-I280
9. Zimmermann N., Wenk A., Kim U., et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 108 (2003) 542-547
10. Poston R., Gu J., Manchio J., et al. Platelet function tests predict bleeding and thrombotic events after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 27 (2005) 584-591
11. Poston R.S., Go J., Brown J.M., et al. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 131 (2006) 122-130
12. Chandler W.L., Fitch J.C.K., Wall M.H., et al. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost 74 (1995) 1293-1297
13. Spiess B.D., and Chandler W.L. Genetic basis of procoagulant and fibrinolytic perioperative adverse events. Best Pract Res Clin Anesthesiol 15 (2001) 195-211
14. Fay W.P., Parker A.C., Condrey L.R., et al. Human plasminogen activator inhibitor-I (PAI-I) deficiency: Characterization of a large kindred with a null mutation in the PAI-I gene. Blood 90 (1997) 204-208
15. Zotz R.B., Winkelman B.R., Nauk M., et al. Polymorphism of platelet membrane IIIa: Human platelet antigen Ib (HPA-Ib/PIA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 79 (1998) 731-735
16. Eriksson P., Kallin B., van'tHooft F.M., et al. Allele-specific increase in basal transcription of the plasminogen activator inhibitor-I gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 92 (1995) 1851-1855
17. Williams M.S., Ng'alla L.S., and Vaida D. Platelet function implications of glycoprotein Ib alpha polymorphisms in African Americans. Am J Hematol 82 (2007) 15-22
18. Oda K., Tamaka N., Arait T., et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: A pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 16 (2007) 592-599
19. Yamsaki Y., Katakani N., Sakamoto K., et al. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care 29 (2006) 2445-2451
20. Markus H.S., Labrum R., Bevan S., et al. Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 37 (2006) 2253-2259
21. Shore-Lesserson L., Manspeizer H.E., DePero M., et al. Thromboelastography-guided transfusion algorithm reduces transfusion in complex cardiac surgery. Anesth Analg 88 (1999) 312-319
22. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study. Lancet 358 (2001) 527-533
23. Steinhubl S.R., Berger P.B., Mann J.T.R., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 288 (2002) 2411-2420
24. Yusuf S., Zhao F., Mehta S.R., et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
25. Chen Z.M., Jiang L.X., Chen Y.P., et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
26. Sabatine M.S., Cannon C.P., Gibson C.M., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
27. Ascione R., Ghosh A., Rogers C.A., et al. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution. Ann Thorac Surg 79 (2005) 1210-1216
28. Chen L., Bracey A.W., Radovancevic R., et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 128 (2004) 425-431
29. Kapetanakis E.I., Medlam D.A., Boyce S.W., et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist's panacea or the surgeon's headache?. Eur Heart J 26 (2005) 576-583
30. Leong J.Y., Baker R.A., Shah P.J., et al. Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg 80 (2005) 928-933
31. Ray J.G., Deniz S., Olivieri A., et al. Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovasc Disord 3 (2003) 3
32. Spiess B.D. Choose one: Damned if you do/Damned if you don't!. Crit Care Med 33 (2005) 1871-1874
33. Engoren M.C., Habib R.H., Zacharaias A., et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74 (2002) 1180-1186
34. Habib R.H., Zacharias A., Schwann T.A., et al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: Implications on operative outcome. Crit Care Med 33 (2005) 1749-1756
35. Koch C.G., Khandwala F., Li L., et al. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 82 (2006) 13-20
36. Banbury M.K., Brizzio M.E., Rajeswaran J., et al. Transfusion increases the risk of postoperative infection after cardiac surgery. J Am Coll Surg 202 (2006) 131-138
37. Leal-Noval S.R., Rincón-Ferrari M.D., García-Curiel A., et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 119 (2001) 1461-1468
38. Basran S., Frumento R.J., Cohen A., et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg 103 (2006) 15-20
39. Rawat S., et al. Impact of blood transfusion during cardiopulmonary bypass on operative outcomes in women undergoing coronary revascularization surgery (2006) 10th International Congress of CV and Thoracic Anesthesia. Prague, Czech Republic, August 28
40. Surgenor S.D., et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 114 suppl (2006) 43-48
41. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999) 409-417
42. DeFoe G.R., Ross C.S., Olmsted E.M., et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting: Northern New England Cardiovascular Disease Study group. Ann Thorac Surg 71 (2001) 769-776
43. Spiess B.D., Royston D., Levy J.H., et al. Platelet transfusions during coronary artery bypass grafting surgery are associated with serious adverse outcomes. Transfusion 44 (2004) 1143-1148
44. Mangano D.T., and Multicenter study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 34 (2002) 1309-1317
45. Karkouti K., Wijeysundera D.N., Yau T.M., et al. Platelet transfusions are not associated with increased morbidity and mortality in cardiac surgery. Can J Anaesth 53 (2006) 279-287